Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations

Lancet

Volumn 355, Issue 9205, 2000, Pages 675-687

  Kuulasmaa, Kari ^a   Tunstall Pedoe, Hugh ^b   Dobson, Annette ^f   Fortmann, Stephen ^f   Sans, Susana ^c   Tolonen, Hanna ^a   Evans, Alun ^d   Ferrario, Marco ^e   Tuomilehto, Jaakko ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b (MONICA Qual Contr Ctr Event R   (United Kingdom)

^c INSTITUT CATALÀ DE LA SALUT   (Spain)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; DATA ANALYSIS; FEMALE; HEALTH CARE POLICY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING;

EID: 0034716468     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)11180-2     Document Type: Article

References (52)

1. Uemura K., Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 41:1988;155-178.
2. Havlik R.J., Feinleib M. Proceedings of the conference on the decline in coronary heart disease mortality. October 24-25, 1978. 1979;National Heart, Lung and Blood Institute, US Department of Health, Education, and Welfare, Washington DC. NIH publication no.79-1610.
3. Tunstall-Pedoe H. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol. 41:1988;105-114.
4. Tunstall-Pedoe H., Kuulasmaa K., Mähönen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet. 353:1999;1547-1557.
5. Pi-Sunyer F.X. Medical hazards of obesity. Ann Intern Med. 199:1993;655-660.
6. Tunstall-Pedoe H., Vanuzzo D., Hobbs M.et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 355:2000;688-700.
7. Rose G. Sick individuals and sick populations. Int J Epidemiol. 14:1985;32-38.
8. Morgenstern H. Uses of ecologic analysis in epidemiologic research. Am J Public Health. 72:1982;1336-1344.
9. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A-M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates and case fatality in 38 populations from 21 countries in 4 continents. Circulation. 90:1994;583-612.
10. Keil U., Kuulasmaa K. WHO MONICA Project: Risk factors. Int J Epidemiol. 18:1989;46-55. (suppl 1).
11. Dobson A., Kuulasmaa K., Moltchanov V.et al. Changes in cigarette smoking among adults in 35 populations in the mid 1980s. Tob Control. 7:1998;14-21.
12. Wolf H.K., Tuomilehto J., Kuulasmaa K.et al. Blood pressure levels in the 41 populations of the WHO MONICA project. J Hum Hypertens. 11:1997;733-742.
13. Hense H.W., Koivisto A-M., Kuulasmaa K., Zaborskis A., Kupsc W., Tuomilehto J. Assessment of blood pressure measurement quality in the baseline surveys of the WHO MONICA Project. J Hum Hypertens. 9:1995;935-946.
14. Döring A., Pajak A., Ferrario M., Grafnetter D., Kuulasmaa K. Methods of total cholesterol measurement in the baseline survey of the WHO MONICA Project. Rev Épidémiol Santé Publique. 38:1990;455-461.
15. Molarius A., Seidell J.C., Kuulasmaa K., Dobson A.J., Sans S. Smoking and relative body weight: an international perspective from the WHO MONICA Project. J Epidemiol Community Health. 51:1997;252-260.
16. Dobson A., Evans A., Ferrario M.et al. Changes in estimated coronary risk in the 1980s: data from 38 populations in the WHO MONICA Project. Ann Med. 30:1998;199-205.
17. Clarke R., Shipley M., Lewington S.et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 150:1999;341-353.
18. MacMahon S., Peto R., Cutler J.et al. Blood pressure, stroke and coronary heart disease, part 1: prolonged differences in blood pressure - prospective observational studies corrected for the regression dilution bias. Lancet. 335:1990;765-774.
19. Law M.R., Wald N.J., Wu T., Hackshaw A., Bailey A. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study. BMJ. 308:1994;363-366.
20. Waterhouse J., Muir C.S., Correa P., Powell J. Cancer incidence in five continents. 1976;IARC, Lyon.
21. Kuulasmaa K, Dobson A for the WHO MONICA Project. Statistical issues related to following populations rather than individuals over time: bulletin of the International Statistical Institute - proceedings of the 51st Session. Istanbul, Turkey: Voorburg: International Statistical Institute, 1997; Book 1; 295-298.
22. Pocock S.J., Cook D.G., Beresford S.A.A. Regression of area mortality rates on explanatory variables: what weighting is appropriate? Appl Stat. 30:1981;286-295.
23. Dobson A., Filipiak B., Kuulasmaa K.et al. Relations of changes in coronary disease rates and changes in risk factor levels: methodological issues and a practical example. Am J Epidemiol. 143:1996;1025-1034.
24. Dawber T.R. The Framingham study: the epidemiology of atherosclerotic disease. 1980;Harvard University Press, Cambridge, MA, USA.
25. Reid D.D., Hamilton P.J.S., McCartney P., Rose G., Jarrett R.J., Keen H. Smoking and other risk factors for coronary heart disease in British civil servants. Lancet. 2:1976;979-984.
26. Relationship of blood pressure, serum cholesterol, smoking habits, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis. 31:1978;201-306.
27. Kannel S.J., Neaton J.D., Wentworth D.et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT: multiple risk factor intervention trial. Am Heart J. 112:1986;825-836.
28. Keys A. Seven countries: a multivariate analysis of death and coronary heart disease. 1980;Harvard University Press, Cambridge, MA, USA.
29. Artaud-Wild S.M., Connor S.L., Sexton G., Connor W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland: a paradox. Circulation. 88:1993;2771-2779.
30. Stewart A.W., Kuulasmaa K., Beaglehole R. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol. 23:1994;505-516.
31. Tunstall-Pedoe H. Autres pays, autres moeurs: theories on why the French have less heart disease than the British. BMJ. 297:1988;1559-1560.
32. Evans A.E., Ruidavets J.B., McCrum E.E.et al. Autres pays, autres coeurs? Dietary patterns, risk-factors and ischaemic heart disease in Belfast and Toulouse. Q J Med. 88:1995;469-477.
33. Sigfusson N., Sigvaldason H., Steingrimsdottir L.et al. Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ. 302:1991;1371-1375.
34. Vartiainen E., Puska P., Pekkanen J., Tuomilehto J., Jousilahti P. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ. 309:1994;23-27.
35. Dobson A.J., McElduff P., Heller R., Alexander H., Colley P., D'Este K. Changing patterns of coronary heart disease in the Hunter Region of New South Wales, Australia. J Clin Epidemiol. 52:1999;761-771.
36. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P. Survival trends, coronary event rates and the MONICA Project-Reply. Lancet. 354:1999;863-864.
37. Anderson K.M., Odell P.M., Wilson P.W.F., Kannel W.B. Cardiovascular disease risk profiles. Am Heart J. 121:1990;293-298.
38. Gordon D.J., Probstfield J.L., Garrison R.J.et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 79:1989;8-15.
39. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet. 354:1999;617-621.
40. Stamler R., Stamler J., Lindberg H.A.et al. Asymptomatic hyperglycaemia and coronary heart disease in middle-aged men in two employed populations in Chicago. J Chronic Dis. 32:1979;805-815.
41. Gey K.F., Puska P., Jordan P., Moser U.K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr. 53:1991;326-334. (suppl 1).
42. Ernst E., Resch K.L. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med. 118:1993;956-963.
43. Barker D.J.P. Fetal origins of coronary heart disease. BMJ. 311:1995;171-174.
44. Tunstall-Pedoe H., Woodward M., Tavendale R., A'Brook R., McCluskey M.K. Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish heart health study: cohort study. BMJ. 315:1997;722-729.
45. Chenet L., McKee M., Leon D., Shkolnikov V., Vassin S. Alcohol and cardiovascular mortality in Moscow; new evidence of a causal association. J Epidemiol Community Health. 52:1998;772-774.
46. Sans S., Kesteloot H., Kromhout D. The burden of cardiovascular diseases mortality in Europe: Task force of the European Society of cardiology on cardiovascular mortality and morbidity statistics in Europe. Eur Heart J. 18:1997;1231-1248.
47. Fuller W.A. Measurement error models. 1987;Wiley, New York.
48. Manson J.E., Tosteson H., Ridker P.M.et al. Primary prevention of myocardial infarction. N Engl J Med. 326:1992;1406-1416.
49. Law M.R., Wald N.J., Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ. 308:1994;367-372.
50. Rose G. Incubation period of coronary heart disease. BMJ. 284:1982;1600-1601.
51. Law M., Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ. 318:1999;1471-1476.
52. Schwartz S., Carpenter K.M. The right answer for the wrong question: consequences of type III error for public health research. Am J Public Health. 89:1999;1175-1180.